QA: ALPINE IMMUNE SCIENCES INC. in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001626199_2019_ALPINE_IMMUNE_SCIENCES_INC.pdf

Logs

warning Similarly named company. Duplicate? None {'details': [{'other_company': 'IMMUNE DESIGN CORP.', 'shared_tokens': {'immune'}}]}

Graph

Absolute values for 0001626199, ALPINE IMMUNE SCIENCES INC.

  xvar xval
0 AssetsCurrent 53,545,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,196,000
3 remainder_Assets 132,000
4 LiabilitiesCurrent 8,127,000
5 LiabilitiesNoncurrent 2,155,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 8,362,000
9 ResearchAndDevelopmentExpense 28,970,000
10 remainder_Expenses 1,156,000
11 remainder_Revenues 2,001,000
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 46,000
  yvar yval
0 Assets 54,873,000
1 Liabilities 10,282,000
2 Expenses 38,488,000
3 Revenues 2,001,000
4 StockholdersEquity 44,591,000
5 NetIncome -36,487,000
6 ComprehensiveNetIncome -36,464,000
7 BaseVar 52,845,000
8 EconomicCapitalRatio 1.23

Edgar->Model Mapping

Feature Distribution

Change over Time